| Title: |
120P Avelumab (AVE), cetuximab (CET) and irinotecan (IRI) for treatment refractory microsatellite stable (MSS) metastatic colorectal cancer (mCRC): Characterization of the circulating immune response in the AVETUXIRI phase II trial |
| Authors: |
Benidovskaya, Elena; Huyghe, Nicolas; Carrasco, Javier; De Cuyper, Astrid; Sinapi, Isabelle; Verstraelen, Eléonore; Goffette, Pierre; Ghaye, Benoît; Papier, M.; Van Maanen, Aline; Castella, Marie-Laure; Galon, Jérôme; Van den Eynde, Marc; the ESMO Gastrointestinal Cancers Congress 2024 |
| Contributors: |
UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie; UCL - (SLuc) Service d'oncologie médicale |
| Source: |
Annals of Oncology, Vol. 35, no.Suppl 1, p. S56 (2024) |
| Publisher Information: |
Elsevier |
| Publication Year: |
2024 |
| Collection: |
DIAL@USL-B (Université Saint-Louis, Bruxelles) |
| Description: |
Background : Clinical efficacy and safety of AVE, CET and IRI have previously been reported for the treatment of refractory MSS mCRC. Here, we aim to characterize the systemic immune response and investigate its potential role in response to immunotherapy. [.] |
| Document Type: |
conference object |
| Language: |
English |
| Relation: |
boreal:299292; http://hdl.handle.net/2078.1/299292 |
| DOI: |
10.1016/j.annonc.2024.05.131 |
| Availability: |
http://hdl.handle.net/2078.1/299292; https://doi.org/10.1016/j.annonc.2024.05.131 |
| Rights: |
info:eu-repo/semantics/openAccess |
| Accession Number: |
edsbas.36C49EE |
| Database: |
BASE |